A post by @FirstSquawk on X.
CHINA APPROVES ELI LILLY'S ORAL GLP-1 DRUG FOR WEIGHT LOSS.
@FirstSquawk on X
Open the post on XPosted by @FirstSquawk on x.com
70
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Muhabbit only has the headline for this one. The full report is at x.com.
Named in this story
Eli Lilly (LLY), oral GLP-1 drug, China
A linked name opens that asset's sentiment page.